These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1540406)

  • 21. Comparison of the antiviral efficacy of ribozymes and antisense RNA directed against bovine leukemia virus rex/tax.
    Cantor GH; Stone DM; McElwain TF; Palmer GH
    Antisense Nucleic Acid Drug Dev; 1996; 6(4):301-4. PubMed ID: 9012866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells.
    Hormes R; Homann M; Oelze I; Marschall P; Tabler M; Eckstein F; Sczakiel G
    Nucleic Acids Res; 1997 Feb; 25(4):769-75. PubMed ID: 9016627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
    Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
    Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological and functional aspects of catalytic RNAs.
    Castanotto D; Rossi JJ; Deshler JO
    Crit Rev Eukaryot Gene Expr; 1992; 2(4):331-57. PubMed ID: 1486242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18.
    Chen Z; Kamath P; Zhang S; Weil MM; Shillitoe EJ
    Cancer Gene Ther; 1995 Dec; 2(4):263-71. PubMed ID: 8548580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV and Ribozymes.
    Scarborough RJ; Gatignol A
    Adv Exp Med Biol; 2015; 848():97-116. PubMed ID: 25757617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1.
    Yu M; Ojwang J; Yamada O; Hampel A; Rapapport J; Looney D; Wong-Staal F
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6340-4. PubMed ID: 8327516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribozyme: a clinical tool.
    Khan AU
    Clin Chim Acta; 2006 May; 367(1-2):20-7. PubMed ID: 16426595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential use of catalytic RNAs in therapy of HIV infection and other diseases.
    Rossi JJ; Cantin EM; Sarver N; Chang PF
    Pharmacol Ther; 1991; 50(2):245-54. PubMed ID: 1763136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a hammerhead ribozyme with cationic liposomes to reduce leukocyte type 12-lipoxygenase expression in vascular smooth muscle.
    Gu JL; Nadler J; Rossi J
    Mol Cell Biochem; 1997 Jul; 172(1-2):47-57. PubMed ID: 9278231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A ribozyme targeted to RNA polymerase gene of infectious bursal disease virus effectively cleaves and inhibits expression of the viral gene product.
    Akin A; Lin TL; Wu CC
    Acta Virol; 1999 Dec; 43(6):341-7. PubMed ID: 10825922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A chimeric tRNA(Lys3)-ribozyme inhibits HIV replication following virion assembly.
    Westaway SK; Larson GP; Li S; Zaia JA; Rossi JJ
    Nucleic Acids Symp Ser; 1995; (33):194-9. PubMed ID: 8643367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retroviral delivery and anti-HIV testing of hammerhead ribozymes.
    Cagnon L; Rossi J
    Methods Mol Biol; 1997; 74():451-7. PubMed ID: 9204460
    [No Abstract]   [Full Text] [Related]  

  • 34. Prospects for antiviral ribozymes and deoxyribozymes.
    Peracchi A
    Rev Med Virol; 2004; 14(1):47-64. PubMed ID: 14716691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cells.
    Gonzalez-Carmona MA; Schüssler S; Serwe M; Alt M; Ludwig J; Sproat BS; Steigerwald R; Hoffmann P; Quasdorff M; Schildgen O; Caselmann WH
    J Hepatol; 2006 Jun; 44(6):1017-25. PubMed ID: 16469406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral ribozymes. New jobs for ancient molecules.
    Menke A; Hobom G
    Mol Biotechnol; 1997 Aug; 8(1):17-33. PubMed ID: 9327395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of hepatitis B virus by hammerhead ribozyme targeted to the poly(A) signal sequence in cultured cells.
    Feng Y; Kong YY; Wang Y; Qi GR
    Biol Chem; 2001 Apr; 382(4):655-60. PubMed ID: 11405228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization in vitro and in vivo of hammerhead ribozymes directed against murine tumor necrosis factoralpha.
    MacKay SL; Tannahill CL; Auffenberg T; Ksontini R; Copeland EM; Moldawer LL
    Biochem Biophys Res Commun; 1999 Jul; 260(2):390-7. PubMed ID: 10403780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of ribozymes for gene therapy.
    Sullivan SM
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):85S-89S. PubMed ID: 7963690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.
    Giordano V; Jin DY; Rekosh D; Jeang KT
    Virology; 2000 Feb; 267(2):174-84. PubMed ID: 10662613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.